test

David Kim

@Paradigm Biocapital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$2.956BTotal holdings31
Assets growth rate13.13%Assets growth rate (2-Q avg)2.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Paradigm Biocapital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 31 positions.

Assets under management

The assets under management (AUM) of Paradigm Biocapital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.956B in assets, with a quarterly growth rate of 13.13% and a 2-quarter average growth rate of 2.56%. The portfolio is managed by David Kim, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
NUVLNuvalent Inc
Recent Activity
Increased 9.37%
17.31%
$511.5M
5M shares@ $102.3 avg price
ACLXArcellx Inc
Recent Activity
Increased 24.74%
13.57%
$400.848M↑ Call
4.8M shares@ $83.51 avg price
ARGXArgenx Se
Recent Activity
Decreased -10.73%
8.81%
$260.401M
480,374 shares@ $542.09 avg price
RVMDRevolution Medicines Inc
Recent Activity
Increased 1.05%
8.16%
$240.994M
5.314M shares@ $45.35 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
Increased 0.14%
4.36%
$128.603M
2.517M shares@ $51.11 avg price
MRUSMerus N V
Recent Activity
Increased 21.55%
4.15%
$122.648M
2.455M shares@ $49.96 avg price
JANXJanux Therapeutics Inc
Recent Activity
Increased 53.45%
3.69%
$109.058M
2.401M shares@ $45.44 avg price
PCVXVaxcyte Inc
Recent Activity
Increased 44.22%
3.5%
$103.361M↑ Call
904,532 shares@ $114.28 avg price
KURAKura Oncology Inc
Recent Activity
Decreased -4.58%
2.87%
$84.634M
4.331M shares@ $19.54 avg price
TARSTarsus Pharmaceuticals Inc
Recent Activity
Increased 0.21%
2.72%
$80.266M
2.44M shares@ $32.89 avg price